These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2548807)

  • 1. Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins.
    Pollow K; Juchem M; Grill HJ; Elger W; Beier S; Henderson D; Schmidt-Gollwitzer K; Manz B
    Contraception; 1989 Sep; 40(3):325-41. PubMed ID: 2548807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins.
    Pollow K; Juchem M; Elger W; Jacobi N; Hoffmann G; Möbus V
    Contraception; 1992 Dec; 46(6):561-74. PubMed ID: 1493716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
    Juchem M; Pollow K
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2171-83. PubMed ID: 2175153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
    Fuhrmann U; Slater EP; Fritzemeier KH
    Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of norethindrone on estrogen and progesterone receptors in the rabbit uterine cytosol (author's transl)].
    Tamaya T; Ishihara S; Motoyama T; Nioka S; Furuta N
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1033-42. PubMed ID: 183990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
    Bergink EW; Hamburger AD; de Jager E; van der Vies J
    J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
    Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
    Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of new 19 nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors.
    Botella J; Porthe-Nibelle J; Paris J; Lahlou B
    J Pharmacol; 1986; 17(4):699-706. PubMed ID: 3560978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites.
    Lemus AE; Zaga V; Santillán R; García GA; Grillasca I; Damián-Matsumura P; Jackson KJ; Cooney AJ; Larrea F; Pérez-Palacios G
    J Endocrinol; 2000 Jun; 165(3):693-702. PubMed ID: 10828854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor binding of norgestimate--a new orally active synthetic progestational compound.
    Juchem M; Pollow K; Elger W; Hoffmann G; Möbus V
    Contraception; 1993 Mar; 47(3):283-94. PubMed ID: 8384965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor in the hypothalamic cytosol of female rats.
    Lee H; Davies IJ; Ryan KJ
    Endocrinology; 1979 Mar; 104(3):791-800. PubMed ID: 436737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3H-ZK 98,734, a new 11 beta-aryl substituted antigestagen: binding characteristics to receptor and serum proteins.
    Pollow K; Juchem M; Grill HJ; Manz B; Beier S; Henderson D; Schmidt-Gollwitzer K; Elger W
    Contraception; 1989 Aug; 40(2):213-32. PubMed ID: 2758842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid as a possible modulator of estrogen, progestin, androgen, and glucocorticoid receptors in the central and peripheral tissues.
    Kato J
    J Steroid Biochem; 1989; 34(1-6):219-27. PubMed ID: 2516582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of gestodene binding to the oestrogen receptor in human malignant breast tissue.
    Iqbal MJ; Colletta AA
    Anticancer Res; 1987; 7(1):45-8. PubMed ID: 3566182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
    Miller MM; Hurd C; Moudgil VK
    J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
    Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
    Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of progestins on the progesterone receptor in guinea pig uterus.
    Saffran J; Loeser BK; Faber LE
    Adv Exp Med Biol; 1979; 117():223-39. PubMed ID: 474278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in oestrogen receptors in malignant and normal breast tissue as identified by the binding of a new synthetic progestogen.
    Iqbal MJ; Colletta AA; Houmayoun-Valyani SD; Baum M
    Br J Cancer; 1986 Sep; 54(3):447-52. PubMed ID: 3756080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.